Trials / Conditions / Localized Resectable Adult Primary Liver Cancer
Localized Resectable Adult Primary Liver Cancer
6 registered clinical trials studyying Localized Resectable Adult Primary Liver Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | 3-Tesla MRI Response to TACE in HCC (Liver Cancer) NCT02057874 | Vanderbilt-Ingram Cancer Center | N/A |
| Completed | Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer NCT01624285 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Completed | Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant NCT00844168 | University of Washington | Phase 1 |
| Terminated | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer NCT00087191 | National Cancer Institute (NCI) | N/A |
| Terminated | BMS-247550 in Treating Patients With Liver or Gallbladder Cancer NCT00023946 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer NCT00238160 | Kyoto University | Phase 3 |